Is Zoetis (ZTS) a Unique Dividend Play in the Pharma Space for 2025?
Zoetis Inc. (NYSE:ZTS) stands out as a top player in the animal health sector, offering a wide range of products for both livestock and pets.
Zoetis Inc. (ZTS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ayrshire Capital Management John Nevin Jr. | 33,025 | $5,150,199 | +1% | 2.47% |
| 2. | Zevenbergen Capital Investments Nancy Zevenbergen | 16,180 | $2,523,271 | +5% | 0.05% |
| 3. | Bourgeon Capital John Zaro | 1,870 | $291,627 | -1% | 0.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.48 | 2,100 | $347,508.00 | 7,590 | 2021-02-19 | Filing | |
| $164.89 | 2,900 | $478,181.00 | 5,490 | 2021-02-19 | Filing | |
| $163.80 | 2,590 | $424,242.00 | 2,590 | 2021-02-19 | Filing | |
| $74.56 | 10 | $745.60 | 17 | 2018-01-11 | Filing | |
| $50.31 | 7 | $352.17 | 7 | 2016-10-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $170.00 | 652 | $110,840.00 | 15,129 | 2025-06-03 | Filing | |
| $170.00 | 326 | $55,420.00 | 15,781 | 2025-03-10 | Filing | |
| $166.14 | 1,210 | $201,029.40 | 11,245 | 2025-03-11 | Filing | |
| $156.68 | 382 | $59,852.26 | 94,194 | 2025-02-19 | Filing | |
| $171.18 | 326 | $55,804.68 | 16,107 | 2025-02-11 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,533,842 | $395,152,660 | 2.75% | |
| 2. | 1,611,579 | $251,325,774 | 2.5% | |
| 3. | 1,519,290 | $236,933,277 | 0.27% | |
| 4. | 709,900 | $110,659,212 | 0.52% | |
| 5. | 392,560 | $61,219,732 | 1.31% |
News See All
14 Best Pharma Dividend Stocks to Buy in 2025
The US pharmaceutical industry has undergone notable shifts in recent years, influenced by factors such as the COVID-19 pandemic, expanded collaborations across the value chain, and ongoing changes in...
Argus Trims Zoetis (ZTS) Price Target to $190, Keeps Constructive View
Zoetis Inc. (NYSE:ZTS) is one of the high-margin pharma stocks to buy now. Argus has trimmed its price target on Zoetis Inc.
10 Best High-Margin Pharma Stocks to Buy Now
The pharmaceutical sector continues to stand out as a resilient and highly profitable corner of the market, even amid global economic uncertainty.
Stifel Downgrades Zoetis (ZTS) Stock, Reduces PT
Zoetis Inc. (NYSE:ZTS) is one of the 10 Worst Aggressive Growth Stocks to Buy According to Short Sellers.
10 Worst Aggressive Growth Stocks to Buy According to Short Sellers
According to Morningstar, stocks have experienced a healthy recovery over the past few months. However, the momentum was insufficient to propel the market to a new high for the year.
Zoetis Inc. (ZTS): A Bull Case Theory
We came across a bullish thesis on Zoetis Inc. (ZTS) on Best Anchor Stocks’ Substack. In this article, we will summarize the bulls’ thesis on ZTS. Zoetis Inc.
Jim Cramer on Zoetis (ZTS): “It Does Seem to Be Dead Money”
We recently published a list of Jim Cramer Talked About These 10 Stocks Recently. In this article, we are going to take a look at where Zoetis Inc.
Jim Cramer Talked About These 10 Stocks Recently
“Every day around here, we have a referendum on stocks, and you can't let it get you down because tomorrow's vote can always be different from today's… Why is it like this?...
Billionaire Paul Tudor Jones' 10 Stocks Picks with Huge Upside Potential
It’s all gloomy regardless of what US President Donald Trump does.
Billionaire Hedge Funds
